Amikacin Articles

Novartis to acquire Nektar unit for $115M

27 October 2008

Expert updates on current CF pipeline

13 October 2008

Greater lung exposure for inhaler than IV

2 June 2008

Transave raises $35M in stock financing

7 April 2008

Bayer and Nektar sign pneumonia drug accord

13 August 2007

Nektar restructures, cutting 25% of jobs

4 June 2007

Strong Ph IIa data on Nektar's inhaled amikacin

28 May 2007

Aerogen initiates Ph II trial of amikacin

10 January 2005

SkyePharma outlines mission to become major player in drug delivery

23 February 2000

NeXstar's MiKasome effective in Phase II

29 March 1999

NeXstar Planning To Split Into Two Companies

19 October 1998

NeXstar Expands MikaSome Trials

9 July 1998

NeXstar Begin Ph II MiKasome Trials

20 November 1997

NeXstar's MiKasome

18 September 1997

Solid Growth For US Firms Despite Strong $

24 July 1997

French Generic Market "Still Weak And Patchy"

16 December 1996

NeXstar Files IND For Liposomal Amikacin

14 October 1996

US Generic, Drug Delivery Firms Discuss Strategies

3 June 1996

- Phase I Study Of DepoAmikacin Completed

22 April 1996

DepoTech's DepoAmikacin: trial news

15 January 1996

India Claws Back "Unintended"Profits

12 June 1995

GIST-BROCADES BIDS FOR PIERREL UNIT

23 May 1994

TAZOCIN EFFECTIVE IN SEVERE INFECTION

16 May 1994

ENCOURAGING RESULTS FOR ZENECA'S MERREM

5 July 1993

AMERICAN HOME HAS CONFIDENCE FOR 1993

12 April 1993

VESTAR DAUNOXOME EARLY FILING SUPRISE

22 March 1993

HOECHST'S TARIVID FOR NF PATIENTS

11 May 1992

"ROLLING" NDA FOR ADRIA'S RIFABUTIN

13 April 1992

Showing 1-28 of 28 articles

Go to beginningPrevious
  • 1
NextGo to end